Spayne Lindsay & Co. advises CVC on the acquisition of Cooper Consumer Health.
On 12 March 2021, our client, CVC Capital Partners Fund VII (“CVC”), a leading global private equity firm, announced that it had agreed to acquire, from Charterhouse Capital Partners (“Charterhouse”), Cooper Consumer Health, a leading European provider of consumer healthcare products across numerous market segments such as: calming and sleeping; vitamins and minerals; sun and skincare; and, footcare. The business supplies c.80,000 pharmacies and drugstores across Europe and has c.€500m revenues.
Michael Lavrysen and Victor Blanchard (Senior Managing Directors at CVC Capital Partners), added:
“Having admired and closely followed Cooper’s progress for many years, we are delighted to now have the opportunity to team up with its strong management team, as well as our new partners Charterhouse, Avista Capital Partners and Yvan Vindevogel. Their knowledge of the Company and experience the sector will be invaluable in realizing our shared vision for the development and long-term growth of the business.”
Yvan Vindevogel (CEO of Damier), added:
“I’ve been working together with CVC in the Consumer Healthcare space, as well as with Charterhouse and Avista Capital Partners, for quite a while now. This new enlarged team will be able to create a true Consumer Health powerhouse and accelerate the already impressive growth of the Company.“
Spayne Lindsay & Co were financial advisors to CVC on the transaction. We are delighted to have been able to help CVC in this benchmark transaction in Consumer Healthcare, one of our core verticals.